RVLP Annual SG&A
$81.98 M
-$5.48 M-6.27%
31 December 2022
Summary:
As of January 27, 2025, RVLP annual selling, general & administrative expenses is $81.98 million, with the most recent change of -$5.48 million (-6.27%) on December 31, 2022. During the last 3 years, it has fallen by -$11.05 million (-11.88%).RVLP Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RVLP Quarterly SG&A
$13.89 M
-$2.31 M-14.27%
30 June 2023
Summary:
As of January 27, 2025, RVLP quarterly selling, general & administrative expenses is $13.89 million, with the most recent change of -$2.31 million (-14.27%) on June 30, 2023. Over the past year, it has dropped by -$6.28 million (-31.15%).RVLP Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RVLP TTM SG&A
-$2.31 B
-$68.27 M-3.05%
30 June 2023
Summary:
As of January 27, 2025, RVLP TTM selling, general & administrative expenses is -$2.31 billion, with the most recent change of -$68.27 million (-3.05%) on June 30, 2023. Over the past year, it has dropped by -$2.40 billion (-2591.61%).RVLP TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RVLP Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -6.3% | -31.1% | -2591.6% |
| 3 y3 years | -11.9% | -3.1% | -2933.4% |
| 5 y5 years | +43.9% | -16.7% | -2578.5% |
RVLP Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | -11.9% | -45.6% | -2530.3% |
RVL Pharmaceuticals Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2023 | - | $13.89 M(-14.3%) | $68.06 M(-8.5%) |
| Mar 2023 | - | $16.20 M(-8.0%) | $74.34 M(-9.3%) |
| Dec 2022 | $81.98 M(-6.3%) | $17.60 M(-13.6%) | $81.98 M(-6.9%) |
| Sept 2022 | - | $20.38 M(+1.0%) | $88.07 M(-4.8%) |
| June 2022 | - | $20.17 M(-15.4%) | $92.54 M(-0.9%) |
| Mar 2022 | - | $23.83 M(+0.6%) | $93.42 M(+8.0%) |
| Dec 2021 | $87.46 M(+20.1%) | $23.69 M(-4.6%) | $86.53 M(+6.0%) |
| Sept 2021 | - | $24.84 M(+18.0%) | $81.64 M(+4.5%) |
| June 2021 | - | $21.05 M(+24.2%) | $78.16 M(+9.4%) |
| Mar 2021 | - | $16.95 M(-9.8%) | $71.44 M(-5.6%) |
| Dec 2020 | $72.82 M | $18.80 M(-12.0%) | $75.67 M(-3.0%) |
| Sept 2020 | - | $21.36 M(+49.0%) | $77.98 M(-4.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2020 | - | $14.34 M(-32.3%) | $81.38 M(-12.1%) |
| Mar 2020 | - | $21.18 M(+0.3%) | $92.55 M(-0.5%) |
| Dec 2019 | $93.03 M(+25.3%) | $21.11 M(-14.7%) | $93.03 M(-1.9%) |
| Sept 2019 | - | $24.75 M(-3.0%) | $94.87 M(+8.3%) |
| June 2019 | - | $25.51 M(+17.8%) | $87.57 M(+11.2%) |
| Mar 2019 | - | $21.66 M(-5.7%) | $78.74 M(+6.1%) |
| Dec 2018 | $74.24 M(+30.4%) | $22.95 M(+31.5%) | $74.24 M(+10.9%) |
| Sept 2018 | - | $17.45 M(+4.7%) | $66.94 M(+6.7%) |
| June 2018 | - | $16.68 M(-2.8%) | $62.75 M(+36.2%) |
| Mar 2018 | - | $17.16 M(+9.6%) | $46.07 M(+59.4%) |
| Dec 2017 | $56.95 M(-13.7%) | $15.65 M(+18.1%) | $28.91 M(+118.1%) |
| Sept 2017 | - | $13.26 M | $13.26 M |
| Dec 2016 | $65.96 M | - | - |
FAQ
- What is RVL Pharmaceuticals annual selling, general & administrative expenses?
- What is the all time high annual SG&A for RVL Pharmaceuticals?
- What is RVL Pharmaceuticals annual SG&A year-on-year change?
- What is RVL Pharmaceuticals quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for RVL Pharmaceuticals?
- What is RVL Pharmaceuticals quarterly SG&A year-on-year change?
- What is RVL Pharmaceuticals TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for RVL Pharmaceuticals?
- What is RVL Pharmaceuticals TTM SG&A year-on-year change?
What is RVL Pharmaceuticals annual selling, general & administrative expenses?
The current annual SG&A of RVLP is $81.98 M
What is the all time high annual SG&A for RVL Pharmaceuticals?
RVL Pharmaceuticals all-time high annual selling, general & administrative expenses is $93.03 M
What is RVL Pharmaceuticals annual SG&A year-on-year change?
Over the past year, RVLP annual selling, general & administrative expenses has changed by -$5.48 M (-6.27%)
What is RVL Pharmaceuticals quarterly selling, general & administrative expenses?
The current quarterly SG&A of RVLP is $13.89 M
What is the all time high quarterly SG&A for RVL Pharmaceuticals?
RVL Pharmaceuticals all-time high quarterly selling, general & administrative expenses is $25.51 M
What is RVL Pharmaceuticals quarterly SG&A year-on-year change?
Over the past year, RVLP quarterly selling, general & administrative expenses has changed by -$6.28 M (-31.15%)
What is RVL Pharmaceuticals TTM selling, general & administrative expenses?
The current TTM SG&A of RVLP is -$2.31 B
What is the all time high TTM SG&A for RVL Pharmaceuticals?
RVL Pharmaceuticals all-time high TTM selling, general & administrative expenses is $94.87 M
What is RVL Pharmaceuticals TTM SG&A year-on-year change?
Over the past year, RVLP TTM selling, general & administrative expenses has changed by -$2.40 B (-2591.61%)